BIOCRYST PHARMACEUTICALS, INC. Retail Land Sale Receivables, Weighted Average Interest Rate (Deprecated 2016-01-31)
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Retail Land Sale Receivables, Weighted Average Interest Rate (Deprecated 2016-01-31) of 2.00% for the 1-month period ending 2011-06-30, per its 10-Q filed 2014-08-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:RetailLandSaleReceivablesWeightedAverageInterestRate · last filed 2014-08-08
- 2011-06-30: Retail Land Sale Receivables, Weighted Average Interest Rate (Deprecated 2016-01-31) 1 month 2.00%.
| Period end | Retail Land Sale Receivables, Weighted Average Interest Rate (Deprecated 2016-01-31) 1 month |
|---|---|
| 2011-06-30 | 2.00% 10-Q · filed 2014-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |